170 related articles for article (PubMed ID: 10446875)
1. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
Buckley LM; Marquez M; Feezor R; Ruffin DM; Benson LL
Arthritis Rheum; 1999 Aug; 42(8):1736-9. PubMed ID: 10446875
[TBL] [Abstract][Full Text] [Related]
2. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
Buckley LM; Marquez M; Hudson JO; Downs RW; Vacek P; Small RE; Poses R
J Rheumatol; 1998 Nov; 25(11):2195-202. PubMed ID: 9818664
[TBL] [Abstract][Full Text] [Related]
3. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
Smith MD; Cheah SP; Taylor K; Ahern MJ
J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
5. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
Ledwich LJ; Clarke K
J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
[TBL] [Abstract][Full Text] [Related]
6. Corticosteroid-induced osteoporosis.
Joseph JC
Am J Hosp Pharm; 1994 Jan; 51(2):188-97; quiz 229-30. PubMed ID: 8160669
[TBL] [Abstract][Full Text] [Related]
7. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
[TBL] [Abstract][Full Text] [Related]
8. High-dose corticosteroid exposure and osteoporosis intervention in adults.
Che M; Ettinger B; Nguyen MT; Pressman AR; Johnston J
Ann Allergy Asthma Immunol; 2006 Oct; 97(4):497-501. PubMed ID: 17069105
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
10. Patient knowledge, beliefs, and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosis.
Blalock SJ; Norton LL; Patel RA; Dooley MA
Arthritis Rheum; 2005 Oct; 53(5):732-9. PubMed ID: 16208664
[TBL] [Abstract][Full Text] [Related]
11. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
Lems WF; Jacobs JW; Netelenbos JC; Dijkmans BA; Bijlsma JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1904-8. PubMed ID: 9856175
[TBL] [Abstract][Full Text] [Related]
13. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
14. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
Curtis JR; Westfall AO; Allison J; Becker A; Melton ME; Freeman A; Kiefe CI; MacArthur M; Ockershausen T; Stewart E; Weissman N; Saag KG
Arch Intern Med; 2007 Mar; 167(6):591-6. PubMed ID: 17389291
[TBL] [Abstract][Full Text] [Related]
15. Trends in prevention of glucocorticoid-induced osteoporosis.
Saag KG; Gehlbach SH; Curtis JR; Youket TE; Worley K; Lange JL
J Rheumatol; 2006 Aug; 33(8):1651-7. PubMed ID: 16845707
[TBL] [Abstract][Full Text] [Related]
16. Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment.
Solomon DH; Levin E; Helfgott SM
J Rheumatol; 2000 Jun; 27(6):1496-500. PubMed ID: 10852277
[TBL] [Abstract][Full Text] [Related]
17. Physician's awareness of the prevention of corticosteroid induced osteoporosis.
Ungprasert S; Wangkaew S; Louthrenoo W
J Med Assoc Thai; 2007 Jan; 90(1):59-64. PubMed ID: 17621734
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
19. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
Amin S; LaValley MP; Simms RW; Felson DT
Arthritis Rheum; 1999 Aug; 42(8):1740-51. PubMed ID: 10446876
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid-induced osteoporosis in patients with uveitis.
Jones NP; Anderton LC; Cheong FM; Whallett A; Stanford MR; Murray PI; Lesnik-Oberstein S; Pavesio C
Eye (Lond); 2002 Sep; 16(5):587-93. PubMed ID: 12194074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
